DermaPure Decellularized Dermal Allograft provides a scaffold for the body’s repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument. When looking to fill or cover a tissue deficit, DermaPure adds a clean canvas to stimulate Tissue Regeneration.

How is DermaPure different?

Unlike alternative processes used for other cellular and tissue based products (CTPs), DermaPure is decellularized with dCELL Technology resulting in nearly no structural disruption and preserves the tissue’s native structure and biomechanical properties.

Benefits:

• Produced using patented dCELL Technology

• Human-derived dermal allograft

• Minimally manipulated to maintain structure

• 99% DNA-free

• Biocompatible while retaining native growth factors, collagen and elastin, preserving natural structure

• Replaces the damaged extracellular matrix so living cells can flourish

• Supports angiogenesis with the presence of vascular-like channels present prior to application

• Permits fibroblasts to attach to the scaffold

• Contains the correct extracellular matrix components to attract and proliferate endothelial cells

Recommended Use For:

• Acute Wounds

• Burns

• Cavity Wounds

• Chronic Wounds

• Deep Wounds

• Dehisced Wounds

• Diabetic Foot

• Granulating/Epithelializing Wounds

Product features:

• Assigned HCPCS code

• Sheet form

• Shelf life greater than 2 years

• Indicated for acute wounds

• Indicated for chronic wounds

• Indicated for diabetic ulcers

• Indicated for pressure ulcers

• Indicated for surgical wounds

• Indicated for third-degree burns

• Indicated for venous ulcers